drugset / Trial / NCT03255174
The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the safety and hemostatic effectiveness of EVARREST as an adjunct to controlling mild to moderate soft hepatic parenchyma or soft tissue bleeding during open hepatic, abdominal, pelvic, retroperitoneal, and thoracic (non-cardiac) surgery in pediatric population.
Timeline
- Start
- 2018-03-20
- Primary completion
- 2025-01-22
- Completion
- 2025-02-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EVARREST Fibrin Sealant Patch | Protein / enzyme biologic | — | — |
Indications
No indication recorded.